Course summary
This full-time Master's programme provides a comprehensive overview of drug safety practices within the drug development process. It addresses key aspects of preclinical drug evaluation through the study of:
- Drug discovery and development
- Safety pharmacology
- Mechanisms of drug-induced toxicities
- Regulatory affairs
- Bioanalytical sciences
Modules
All years: preclinical models for drug evaluation; research and analytical methods in safety pharmacology; toxicology and safety pharmacology; experimental design for safety pharmacology; molecular mechanisms of toxicity; research project.
Assessment method
Research project.
Entry requirements
A 2.2 Honours degree or above in a related scientific discipline e.g. biosciences, chemistry, biomedical, medical, pharmaceutical, pharmacological, or toxicological studies; applications are also welcome from candidates with non standard qualification, with significant relevant experience. IELTS at 6.0 or the equivalent.
Fees and funding
Tuition fees
England | £9230 | Whole course |
Northern Ireland | £9230 | Whole course |
Scotland | £9230 | Whole course |
Wales | £9230 | Whole course |
Republic of Ireland | £9230 | Whole course |
EU | £23028 | Whole course |
International | £23028 | Whole course |
Channel Islands | £23028 | Whole course |
Additional fee information
Provider information
University of Bradford
Richmond Road
Bradford
BD7 1DP